Skp2 is an F-box protein that forms the SCF complex with Skp1 and Cullin-1 to constitute an E3 ligase for ubiquitylation. Ubiquitylation and degradation of p27 are critical for Skp2-mediated entry to the cell cycle, and overexpression and cytosolic accumulation of Skp2 have been clearly associated with tumorigenesis, although the functional significance of the latter is still unknown. Here we show that Akt/protein kinase B (PKB) interacts with and directly phosphorylates Skp2. We find that Skp2 phosphorylation by Akt triggers SCF complex formation and E3 ligase activity. A phosphorylation-defective Skp2 mutant is drastically impaired in its ability to promote cell proliferation and tumorigenesis. Furthermore, we show that Akt-mediated phosphorylation triggers 14-3-3β-dependent Skp2 relocalization to the cytosol, and we attribute a specific role to cytosolic Skp2 in the positive regulation of cell migration. Finally, we demonstrate that high levels of activation of Akt correlate with the cytosolic accumulation of Skp2 in human cancer specimens. Our results therefore define a novel proto-oncogenic Akt/PKB-dependent signalling pathway.
The ubiquitin-proteasome system regulates the cell cycle through the control of protein ubiquitylation and degradation 1,2 . One of the key ubiquitin ligases (E3 ligase) in this process is the Skp1/Cul-1/F-box (SCF) complex, which consists of Skp1, Cullin-1 (Cul-1) and RBX1, as well as an F-box protein, all required for its E3 ubiquitin ligase activity. Disruption of this complex severely ablates its enzymatic activity 1, 2 . Skp2 (S-phase kinase associated protein-2) is an SCF F-box protein and is responsible for substrate recognition 1,2 . It binds to p27 and targets it for ubiquitylation and degradation [3] [4] [5] . Overexpression of Skp2 induces cell cycle entry, and the degradation of p27 is required for Skp2-mediated cell cycle progression 6, 7 . Skp2 deficiency shows elevated p27 protein levels and a profound impairment in proliferation accompanied by nuclear enlargement, polypoidy and centrosome overduplication 8, 9 . Overexpression of Skp2 is frequently observed in human cancers of diverse histology, whereas in most human cancers a lower level of p27 is an adverse prognostic marker 1,2 . Skp2 cooperates with H-Ras G12V to transform primary rodent fibroblasts 10 . Overexpression of Skp2 in the T-cell compartment cooperates with N-Ras to induce T-cell lymphomas 11 , and prostate-specific expression of Skp2 leads to prostatic intraepithelial neoplasia 12 . These observations suggest that Skp2 overexpression may contribute to tumorigenesis.
Although substantial advances have been made in understanding the mechanisms that control its levels of expression, the molecular mechanisms by which Skp2 activity within the SCF complex and its subcellular localization are regulated are currently unknown. This is of further relevance because, in human cancer, Skp2 is frequently found aberrantly localized in the cytosol. Here we show that phosphorylation of Skp2 by Akt/PKB constitutes a molecular switch that critically controls the formation, localization and function of the Skp2-SCF complex.
RESUltS

Akt/PKB interacts with and phosphorylates Skp2
Skp2 is phosphorylated during G1/S transition 1,2, 13 . Mitogens such as epidermal growth factor (EGF) can also lead to Skp2 phosphorylation 14 . However, the functional relevance of this phosphorylation event is unclear and the kinases that execute it are still unknown. Because EGF can activate both the phosphatidylinositol-3-OH kinase (PI(3) K)/Akt and the mitogen-activated protein kinase (MAPK) pathways, we speculated that Skp2 might be the phosphorylation target of one of these pathways. We therefore tested whether Akt/PKB might be a Skp2 kinase. Skp2 was found to interact with Akt1 in reciprocal co-immunoprecipitation experiments (Fig. 1a-c) . Interaction between endogenous Skp2 and Akt1 was detected on insulin-like growth factor-1 (IGF-1) stimulation, whereas the interaction was abolished by the PI(3)K inhibitor LY294002, suggesting that Akt activity may favour the formation of the Akt/Skp2 complex (Fig. 1d) . In support of this notion, we found that an Akt1-kinase-dead mutant (K179A) interacted with exogenous Skp2 much less effectively than the constitutively active Akt1 (data not shown). In glutathione S-transferase (GST) pulldown assays, Akt1 was able to interact with Skp2 directly (Fig. 1f) .
We next determined whether Skp2 was a substrate for Akt1 in vitro. Skp2 was readily phosphorylated by recombinant active Akt1 (Fig. 2a) . Phosphorylation of Skp2 by Akt1 was comparable to phosphorylation of TSC2, a well-known Akt substrate, by Akt1 ( Supplementary Information,  Fig. S1b ) [15] [16] [17] [18] . The Scansite program 19 (http://scansite.mit.edu) identifies Skp2 Ser 72 (S72) within an Akt consensus site (RXRXXS/T, where X is any amino acid) identified at medium stringency, which is conserved from rat to human (Fig. 2b) . To determine whether S72 is a site for Aktmediated Skp2 phosphorylation, we mutated this residue from serine to alanine (S72A) and used this Skp2 mutant in kinase assays in vitro. Indeed, Akt-mediated phosphorylation of Skp2 S72A was markedly reduced (Fig. 2c) , even though Skp2 S72A still interacted with Akt as efficiently as wild-type (WT) Skp2 (Fig. 1e) . Similarly, in vivo phospholabelling experiments and western blot analysis with a phospho-Akt substrate antibody revealed that a constitutively active Akt1 (Mri-Akt) phosphorylated WT Skp2 but not Skp2 S72A (Fig. 2d, e) .
To verify whether S72 is phosphorylated by Akt, we next performed mass spectrometry analysis. Skp2 phosphorylated in vivo (Skp2-P) and unphosphorylated Skp2 (Skp2-C) was isolated from 293T cells, digested with trypsin and analysed by matrix-assisted laser desorption ionizationreflectron time-of-flight (MALDI-reTOF) mass spectrometry ( Fig. 2f ; Supplementary Information, Fig. S1a) . Peptide patterns were then compared for differences. One m/z peak, at 1,671.88 atomic mass units (amu), was observed in the spectra of 'Skp2-P' that was absent from those of 'Skp2-C' . The m/z value mapped to the predicted, monophosphorylated fragment of the Skp2 sequence (LKS 72 KGS 75 DKDFVIVR) with monoisotopic ( 12 C) mass discrepancies of less than 40 p.p.m. Next, the same peptide was selectively retrieved by metal-affinity chromatography 20 and reanalysed by MALDI-TOF/TOF tandem mass spectrometry (MS/MS) sequencing. The presence of unique fragment ions confirmed the identity and the monophosphorylation state (characteristic loss of 98 amu) for the peptide and allowed us to narrow down the site of phosphorylation to either S72 or S75. In contrast, in similar experimental conditions, the phosphorylated peptide at 1,671.88 amu was not identified when analysing a Skp2 S72A mutant (designed 'S72A-P'), whereas the non-phosphorylated mutant peptide was detected, strongly suggesting that S72 is the site for Akt-mediated Skp2 phosphorylation in vivo. Similar results were also obtained when using Skp2 phosphorylated in vitro by recombinant Akt1 (data not shown, and Supplementary Information, Fig. S1c, d ).
Using a phospho (S72)-Skp2 specific antibody that we generated, we found that Mri-Akt could phosphorylate Skp2, but not Skp2 S72A (Fig. 2g) . In PC-3 prostate cancer cells, where Akt is constitutively a b
Rec Akt DFVIVR peptide from GFP-Skp2 S72A, was phosphorylated at S72 by Akt in vivo. (g) Akt induces Skp2 phosphorylation at S72 in vivo. 293T cells were transfected with the indicated plasmids, and harvested for western blot analysis using an anti-phospho (S72)-Skp2 antibody. (h, i) Endogenous Skp2 is phosphorylated by Akt at S72. PC-3 prostate cancer cells treated for 5 h with 20 µM LY294002 (LY, h) or 10 nM rapamycin (Rapa, i) were harvested for immunoprecipitation (IP), followed by western blot analysis with an anti-phospho-(S72)-Skp2 antibody. (j) EGF induces Skp2 phosphorylation at S72 by means of Akt. 293T cells were serum-starved (0.1% FBS) for 2 days, treated with EGF (100 ng ml 
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Total cell lysates (His) 6 from a representative experiment performed in triplicate. Asterisk, P < 0.05, **P < 0.01 (Student's t-test, n = 3). (e) p27 protein levels are regulated by Skp2 and Skp2 S72D, but not Skp2 S72A. p27 protein expression in LNCaP cells stably transfected with Mock, Skp2, Skp2 S72A, or Skp2 S72D. (f, g) S72 phosphorylation is critical for Skp2-mediated tumorigenesis. LNCaP cells mock-transfected or stably transfected with Skp2, Skp2 S72A or Skp2 S72D were injected into nude mice (n = 5 for each group) and followed up for tumorigenesis (see Methods). Pictures in g were taken 4 weeks after injection. Results are presented as means ± s.d. from two independent experiments. Asterisk, P < 0.05; two asterisks, P < 0.01 (Student's t-test). Uncropped images of blots are shown in Supplementary Information, Fig. S16 . active, endogenous Skp2 was phosphorylated at S72 (Fig. 2h) , whereas LY294002 drastically decreased its phosphorylation (Fig. 2h) .
Because the p70 S6 kinase (S6K) is activated by Akt, we determined whether S6K could mediate Akt-induced phosphorylation of Skp2 S72.
Rapamycin, a well-known potent inhibitor of mTOR, abrogated S6K activity towards S6, whereas phosphorylation of Skp2 S72 was unaffected (Fig. 2i) , suggesting that S6K is not involved in the Akt-dependent phosphorylation of Skp2 S72. In addition, treatment with EGF induced the activation of Akt and phosphorylation of Skp2 S72, which was inhibited by wortmannin but not by the MAP kinase/ERK kinase 1 (MEK1) inhibitor U0126, suggesting that the EGF-mediated phosphorylation of Skp2 S72 occurs through an Akt-dependent pathway independently of MAPK-p90 ribosomal S6 kinase (RSK) activation (Fig. 2j) . These results provide strong support for the direct phosphorylation of Skp2 S72 by Akt/ PKB both in vitro and in vivo. 
S72 phosphorylation is critical for the biochemical and protooncogenic functions of Skp2
We next determined whether phosphorylation of Skp2 S72 modulates its E3 ligase activity towards p27. WT Skp2 and the phosphomimetic Skp2 S72D mutant readily promoted the ubiquitylation of endogenous and exogenous p27, whereas Skp2 S72A was profoundly impaired in this function ( Fig. 3a; Supplementary Information, Fig. S2a ). Although phosphorylation of p27 at T187 is proposed as an important event for the interaction of p27 with the Skp2-SCF complex 1 , we found, surprisingly, that Skp2-mediated ubiquitylation of WT p27 and p27 T187A was comparable ( Supplementary Information, Fig. S3a ). Similarly, the interaction of Skp2 with WT p27 and p27 T187A was also comparable ( Supplementary Information, Fig. S3b ), which is consistent with the results from the Roberts group 21 showing that the interaction of p27 with Skp2 regulated by p27 T187 phosphorylation is dependent on the cell type.
Whereas WT Skp2 and Skp2 S72D promoted the degradation of p27, Skp2 S72A markedly decreased this activity ( Fig. 3b ; Supplementary  Information, Fig. S2b ). It should be noted that within this time frame there was no significant change in cell-cycle distribution, suggesting GST-14-3-3β
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Mock Mri-Akt Cells with cytosolic Skp2 bound to glutathione-agarose beads were incubated with in vitro translated GFP-35 S-Skp2, which was preincubated for 30 min with recombinant Akt kinase at 30 °C, washed and subjected to 8% SDS-PAGE, followed by autoradiography. (e) Phosphorylation-dependent regulation of Skp2 interaction with 14-3-3β. 293T cells were transfected with plasmids as indicated, and cells were harvested for co-immunoprecipitation. (f) 14-3-3β, but not 14-3-3γ, mediates Akt-dependent cytosolic localization of Skp2. 293T cells were transfected with small interfering RNA (siRNA) and plasmids as indicated, and harvested for immunofluorescence analysis. Cells (100-200) were scored and a representative result from three independent experiments is shown. Scale bar, 10 µm. Uncropped images of blots are shown in Supplementary Information, Fig. S16 . that p27 degradation is not caused by variation in cell cycle status ( Supplementary Information, Fig. S2c ). The inability of Skp2 S72A to promote the ubiquitylation and degradation of p27 was also not due to its inability to interact with p27 or a decrease in its expression level ( Fig. 3b; Supplementary Information, Fig. S2d ). Furthermore, LY294002 or wortmannin suppressed Skp2-mediated p27 ubiquitylation (Fig. 3a) . These results suggest that Akt activity and phosphorylation of Skp2 S72 promote Skp2 E3 ligase activity.
Skp2 overexpression is known to promote cell proliferation by triggering p27 degradation 6, 7 . We therefore determined whether S72 phosphorylation regulates Skp2-mediated cell proliferation. Both Skp2 and the S72D mutant increased the number of cells in S phase, whereas Skp2 S72A was markedly impaired in this activity ( Fig. 3c ; Supplementary Information, Fig. S3c ). LY294002 or wortmannin suppressed the Skp2-mediated increase in the number of S-phase cells (Fig. 3c) . ) for 3 days, and plated for cell migration assays (Methods). Migrated cells were counted from three random fields, and means ± s.d. were calculated. GRP78 (glucose regulated protein 78) served as a loading control. Representative results from two independent experiments are shown. Two asterisks, P < 0.01; three asterisks, P < 0.001 (Student's t-test, n = 3). Scale bar, 50 µm. (b) Loss of Skp2 impairs cell migration. Skp2 WT and Skp2 −/− primary MEFs were plated for cell migration assays. Migrated cells were counted from three random fields, and means ± s.d.
were calculated. Representative results from three independent experiments are shown. Two asterisks, P < 0.01 (Student's t-test, n = 3). Scale bar, 50 µm. To study the role of Skp2 and Skp2 mutants in tumorigenesis, we generated LNCaP prostate cancer cells with stable overexpression of Skp2 or Skp2 mutants for tumorigenic potential. Overexpression of WT and Skp2 S72D, but not Skp2 S72A, markedly enhanced LNCaP proliferation and decreased p27 protein levels (Fig. 3d, e) . Whereas Skp2 and Skp2 S72D profoundly promoted tumorigenesis in comparison with the mock control, Skp2 S72A completely lost this activity (Fig. 3f, g ).
Skp2 phosphorylation regulates SCF complex formation and activity
Because the integrity of Skp2-SCF complex is critical for Skp2 E3 ligase activity, we next determined whether activation of the PI(3)K/ Akt pathway could regulate the Skp2-SCF complex. Mri-Akt enhanced the interaction of exogenous Skp2 with endogenous Skp1 and Cul-1, whereas wortmannin suppressed the formation of the Skp2-Skp1 complex (Fig. 4a) . In this cell culture condition, we did not observe an appreciable change in S-phase cell numbers by either the activation or inhibition of Akt ( Supplementary Information, Fig. S4) .
Similarly, suppression of the PI(3)K/Akt pathway profoundly impaired endogenous Skp2-SCF complex formation, whereas we observed a slight increase in the formation of this complex after activation of Akt (Fig. 4b) . In agreement with these findings, WT Skp2 and Skp2 S72D readily complexed with endogenous Skp1 and Cul-1, whereas Skp2 S72A significantly decreased its interaction with Skp1 and Cul-1 (Fig. 4c) .
The Skp2-SCF complex isolated from cells transfected with WT Skp2 or its mutants was used in an in vitro p27 ubiquitylation assay. The Skp2-SCF complex readily promoted p27 ubiquitylation ( Supplementary Information, Fig. S5a ): the complex failed to induce p27 ubiquitylation unless p27 had been phosphorylated by the cyclin A-Cdk2 complex before this event ( Supplementary Information,  Fig. S5a ). The ability of Skp2 S72A to complex with Skp1 and Cul-1 and promote p27 ubiquitylation was markedly impaired when compared with that of WT Skp2 and the Skp2 S72D mutant ( Supplementary Information, Fig. S5a ). Furthermore, Mri-Akt significantly increased Skp2-SCF complex formation and p27 ubiquitylation, whereas LY294002 decreased this effect ( Supplementary  Information, Fig. S5b ). We further showed that the SCF complex contained Skp2 phosphorylated on S72 (Fig. 4d, e) , whereas calf intestinal alkaline phosphatase (CIP) induced Skp2 S72 dephosphorylation and disrupted the interaction between Skp2 and Skp1 (Fig. 4f) . In addition, the lysates depleted in Skp1 decreased the phosphorylation of Skp2 S72 and Cul-1 (Fig. 4e) . GST pulldown assays showed that whereas Mri-Akt, which induced phosphorylation of Skp2 S72 (Fig. 2d, g ), greatly increased Skp1 and Skp2 interaction in vitro, Skp2 S72A markedly decreased its interaction with Skp1 (Fig. 4g) . These results strongly suggest that Akt positively regulates Skp2-SCF complex formation, therefore enhancing its E3 ligase activity through phosphorylation of Skp2 S72.
Akt-mediated phosphorylation induces cytosolic localization of Skp2
Skp2 normally resides in the nucleus; however, cytosolic relocalization of Skp2 has been observed in several human cancers [22] [23] [24] [25] . However, the molecular mechanisms underlying this phenomenon and its biological consequence are currently unknown. Loss or mutation of the tumour suppressor PTEN is frequently observed in human cancers, resulting in marked activation of Akt 26, 27 . Akt/PKB may represent a potential candidate for triggering the relocalization of Skp2 to the cytosol, given that phosphorylation of Akt substrates by Akt often results in a change in protein localization 28, 29 . Immunofluorescence revealed that although Skp2 was localized in the nucleus, Mri-Akt induced the relocalization of Skp2 to the cytosol in about 40% of cells. In contrast, this effect was markedly reduced with Skp2 S72A (Fig. 5a ; Supplementary Information, Fig. S6a ). Skp2 S72D relocalized to the cytosol even without Mri-Akt, but the addition of Mri-Akt did not enhance the accumulation of S72D in the cytosol ( Fig. 5a ; Supplementary Information, Fig. S6a ; and data not shown). We further demonstrated that Akt activation on IGF-1 stimulation or MriAkt overexpression induced the relocalization of endogenous Skp2 to the cytosol, as determined by immunofluorescence and fractionation/ western blot analyses (Fig. 5b, c, f; Supplementary Information, Fig. S6b ).
We found that phosphorylation of Skp2 S72 was detected predominantly in the cytosol and not in the nucleus (Fig. 5d) . We next determined the kinetics of phosphorylation of Skp2 S72 and cytosolic Skp2 localization after stimulation with IGF-1. IGF-1 induced the activation of Akt and the phosphorylation of Skp2 S72 at 30 min, which lasted for several hours (Fig. 5e) . Strikingly, wortmannin markedly suppressed IGF-1-induced phosphorylation of Skp2 S72 (Fig. 5e) . Cytosolic accumulation of Skp2 occurred as early as 1 h after IGF-1 treatment, and was significantly blocked by wortmannin (Fig. 5f ). Within this time frame there was no significant change in cell cycle distribution after treatment with IGF-1 ( Supplementary Information, Fig. S7 ). We obtained similar results in IMR90 cells. At 1 h after treatment with IGF, up to 75-80% of cells showed accumulation of Skp2 in the cytosol, although the cell cycle distribution was minimally affected ( Supplementary  Information, Fig. S8a, b, d ). Once again, treatment with IGF led to the activation of Akt accompanied by phosphorylation of Skp2 S72, which was abrogated by wortmannin ( Supplementary Information, Fig. S8c) . Our results therefore suggest that Akt induces the phosphorylation of Skp2 S72, in turn resulting in the cytosolic relocalization of Skp2.
14-3-3β interacts with Skp2 and is required for Akt-mediated cytosolic relocalization of Skp2
Akt phosphorylation is known to trigger the nuclear export of proteins. We therefore tested whether phosphorylation of Skp2 S72 would prevent its nuclear localization. In fact, the Skp2 sequence PRKRLKS (where S is at residue 72) was identified as a putative nuclear localization sequence (NLS) ( Supplementary Information, Fig. S9a ). We fused this putative NLS and its mutant sequences (S72A or S72D) to green fluorescent protein (GFP) and examined their ability to promote the nuclear import of GFP. We found that neither mutant promoted the nuclear localization of GFP, whereas the NLS from simian virus 40 large T antigen fused to GFP did so readily ( Supplementary Information, Fig. S9a ). These results suggested that the PRKRLKS sequence from Skp2 might not function sufficiently as an NLS and that the Akt-dependent cytosolic accumulation of Skp2 may be due to enhanced nuclear export. In full agreement with this hypothesis, leptomycin B (LMB), which blocks the nuclear export of proteins, significantly prevented the Akt-mediated cytosolic localization of Skp2 ( Supplementary Information, Fig. S9b ). Although the PRKRLKS sequence from Skp2 is not functionally sufficient as a NLS in our assays, it is required for the nuclear localization of Skp2: it has been demonstrated that a Skp2 mutant devoid of this sequence primarily localizes to the cytoplasm 30 . The 14-3-3 protein controls a variety of biological processes through the regulation of partner protein localization 31 . It binds to phosphoserine/phosphothreonine-containing motifs in a sequence-specific manner 31 . Because several Akt substrates interact with 14-3-3 after Aktmediated phosphorylation, which in turn results in a change of protein localization [32] [33] [34] [35] , we examined whether 14-3-3 mediates the cytosolic localization of Skp2 after the activation of Akt. Co-immunoprecipitation experiments revealed that endogenous Skp2 interacted with endogenous 14-3-3β but not with 14-3-3γ and 14-3-3θ (Fig. 6a) , although we observed a weak interaction between exogenous Skp2 and 14-3-3γ (data not shown). Suppression of the PI(3)K/Akt pathway by LY294002 or PTEN significantly abolished this interaction (Fig. 6b) . We further showed that the interaction of Skp2 with 14-3-3β was enhanced by IGF-1 through the PI(3)K/Akt-dependent pathway (Fig. 6c) . GST pulldown assays revealed that 14-3-3β interacted with Skp2 directly and that Akt profoundly enhanced this interaction (Fig. 6d) . Whereas Skp2 and Skp2 S72D interacted effectively with 14-3-3β, Skp2 S72A compromised this interaction (Fig. 6e) , suggesting that phosphorylation of Skp2 S72 is critical for the interaction of Skp2 with 14-3-3β. We next determined whether 14-3-3β is required for the Akt-mediated cytosolic relocalization of Skp2. The 14-3-3β and 14-3-3γ small interfering RNAs profoundly suppressed the expression of 14-3-3β and 14-3-3γ proteins, respectively ( Supplementary Information, Fig. S10a ). In particular, silencing 14-3-3β expression inhibited the Akt-mediated cytosolic relocalization of Skp2 ( Fig. 6f; Supplementary Information, Fig. S10b) . Similarly, silencing 14-3-3β expression also decreased the cytosolic localization of Skp2 S72D ( Supplementary Information, Fig. S10c ). As expected, silencing 14-3-3γ expression failed to affect the Akt-mediated cytosolic relocalization of Skp2 (Fig. 6f) . These results suggest that 14-3-3β is required for Skp2 cytosolic relocalization induced by Akt.
Cytosolic Skp2 mediates cell migration
Skp2 overexpression is frequently observed in advanced human cancers. Skp2 may have a function in tumour invasion and metastasis. We examined whether Skp2 has a function in cell migration, which underlies these steps in tumour progression. Overexpression of Skp2 and Skp2 S72D in murine embryonic fibroblasts (MEFs) markedly enhanced cell migration, whereas Skp2 S72A did not (Fig. 7a) . We next determined whether Skp2 is required for cell migration. Skp2 −/− MEFs showed a profound defect in cell migration (Fig. 7b, c) . Similarly, in wound scratch assays, loss of Skp2 significantly delayed wound closure ( Supplementary Information, Fig. S11a ). Because advanced cancers often possess cytosolic Skp2 (refs 22-25), we hypothesized that Skp2 relocalization to the cytosol would favour cell motility. To test this possibility, we created a Skp2-NES (nucleus export signal) construct in which the NES was fused to the carboxy terminus of Skp2. Immunofluorescence reveals that Skp2-NES was predominantly localized in the cytosol (Fig. 7d, upper panel) . Restoration of Skp2-NES rescued the migration defect in Skp2 −/− MEFs ( Fig. 7c; Supplementary Information, Fig. S11a ). This function of Skp2-NES is probably independent of its ability to promote p27 degradation, because Skp2-NES did not form the Skp2-SCF complex efficiently and failed to induce downregulation of p27 ( Fig. 7d ; Supplementary Information, Fig. S11b ).
Cytosolic Skp2 correlates with activated Akt levels, PtEN loss and metastasis in human cancers
Because Akt induced Skp2 cytosolic relocalization, we next determined whether Skp2 localization correlates with activated Akt (pAkt) and PTEN levels in cancer specimens. We immunoassayed Skp2, pAkt and PTEN in colon and prostate tumour microarrays (TMAs). Of 84 cases of colonic adenocarcinoma, 16 cases showed cytoplasmic Skp2 staining in infiltrating carcinoma cells, in contrast with normal colonic mucosa from the same whole section of tissue or from control tissue cores on the TMA; normal colonic mucosa showed scattered nuclear staining in the crypts and glands (Fig. 8a) . Sequential sections showed high levels of pAkt ( Fig. 8a, c; Supplementary Information, Fig. S12a ; P < 0.003) and low levels of PTEN (Fig. 8a, c; Supplementary Information, Fig. S12a ; P < 0.008) in these tumours. The correlation between cytoplasmic Skp2 and high levels of pAkt was also highly significant in prostatic adenocarcinomas, and these cases also showed low PTEN levels ( Fig. 8b, c;  Supplementary Information, Fig. S12b ; P < 0.001). In agreement with the role of cytosolic Skp2 in cell migration, cytosolic Skp2 strongly correlates with lymph node metastasis in colon cancers ( Fig. 8c; Supplementary  Information, Fig. S12a , P = 0.03). These results show that cytosolic Skp2 strongly correlates with pAkt levels, PTEN loss and metastasis in human cancers, further implying that Skp2 cytosolic relocalization may have a function in promoting tumour metastasis.
Evolutionary conservation of the functional and biochemical cross-talk of Akt-Skp2
Skp2 S72 is conserved in many organisms from rat to primates (Fig. 2b) . However, this residue is not conserved in mouse Skp2 (mSkp2), raising the question of when and how this regulatory pathway evolved. We therefore tested the consequences of Akt activation in murine cells. We found that both Akt-mediated mSkp2 phosphorylation and the functional consequences of this event still occur in murine cells. Although Akt did trigger mSkp2 phosphorylation in vivo and even in vitro ( Supplementary  Information, Fig. 13a-c) , it phosphorylated mSkp2 in vitro much less efficiently than the human Skp2 protein ( Supplementary Information,  Fig. 13a ), demonstrating that mSkp2 is a poor direct substrate of Akt. However, SCF complex formation with mSkp2 was also enhanced by Mri-Akt ( Supplementary Information, Fig. 13c ). Akt-mediated cytosolic localization of mSkp2 was also observed ( Supplementary Information,  Fig. 13d ). In agreement with these findings, in Pten −/− MEFs, in which Akt is constitutively active, mSkp2 accumulated in the cytosol and relocalized in the nucleus after treatment with LY294002 ( Supplementary  Information, Fig. 13e ). These results therefore support the notion that the Akt-Skp2 pathway is evolutionarily conserved even though Skp2 may not be a direct target of Akt in murine cells.
DiSCUSSiON
We show that phosphorylation of Skp2 S72 by Akt is required for Skp2 E3 ligase activity and for tumorigenesis. Phosphorylation of Skp2 S72 provides a molecular switch that orchestrates the formation of the SCF complex. The proto-oncogenic PI(3)K/Akt pathway can therefore regulate Skp2 protein levels through the enhancement of Skp2 transcription 36 and stability (see ref. 30 ), its subcellular localization, and, importantly, the function of the SCF complex through Skp2 phosphorylation. Taken together, these findings identify PI(3)K/Akt signalling as a major regulatory pathway of Skp2 function at multiple levels. Very recently, Skp2 was shown to be phosphorylated by Cdk2 at S64; phosphorylation at this residue also regulates Skp2 stability 37 . However, we found that phosphorylation of Skp2 at S64 by Cdk2 was not required for formation of the Skp2-SCF complex ( Supplementary  Information, Fig. S14a ).
It should be noted that varying Akt activity, by varying culture conditions, can affect the ability of Skp2 and Skp2 S72A to form a Skp2-SCF complex. This is because Skp2 S72A showed only a minor change in SCF complex formation compared with WT Skp2 in 0.1% fetal bovine serum (FBS), in which Akt activity was low, whereas Skp2 S72A was impaired in forming a SCF complex on Mri-Akt overexpression in comparison with WT Skp2 (Supplementary Information, Fig. S15a ).
In addition, the Scansite program also predicts Skp2 T21 as a possible additional Akt phosphorylation site at low stringency (data not shown). We did indeed find that Akt-mediated phosphorylation of the Skp2 T21A mutant was partly decreased in vitro. Moreover, the ability of the Skp2 T21A mutant to form a SCF complex was also decreased ( Supplementary Information, Fig. S15b, c) . These results suggest that T21 site on Skp2 may be an additional site for the effect of Akt on formation of the Skp2-SCF complex, at least in vitro. However, because the stringency of this site as assessed by a Scansite analysis is low, it remains to be determined whether this site is at all relevant in vivo.
The crystal structure of the Skp2-SCF complex has been resolved 38 . However, the amino-terminal Skp2 tail (residues 1-108, encompassing the S72 sites) was omitted in these structural studies, suggesting that the N-terminal Skp2 tail is not required for the formation of the SCF complex itself. By contrast, it may contain an inhibitory domain that, in the context of the full-length protein, hinders the Skp2 interaction interface for Skp1 binding. Akt-mediated phosphorylation of Skp2 S72 may induce its conformational change, in turn allowing the interaction of Skp2 with Skp1. In support of this notion, a Skp2 mutant (residues 91-424) devoid of the N-terminal tail forms a SCF complex much more efficiently than WT Skp2 in the cytosol and the nucleus (Fig. 4h, i) .
Skp2 normally localizes to the nucleus and aberrantly localizes to the cytosol during cancer progression by mechanisms that are as yet unknown [22] [23] [24] [25] . We provide convincing evidence that cytosolic Skp2 localization is regulated by Akt through the phosphorylation of Skp2 S72. Although Skp2 is also phosphorylated by Cdk2 at S64 (ref. 37) , phosphorylation of Skp2 at S64 does not regulate the cytosolic localization of Skp2 ( Supplementary Information, Fig. S14b ). Our results showing that the cytosolic localization of Skp2 strongly correlates with pAkt level, PTEN loss and cancer metastasis suggest that cytosolic Skp2 may be important in tumour metastasis. In agreement with this notion, we find that Skp2 has an essential and dose-dependent function in cell migration, whereas a cytosolic Skp2 mutant restores the migration defects in Skp2 −/− MEFs. In conclusion, we show that Akt-mediated Skp2 phosphorylation is critical for formation of the SCF complex, cytosolic localization of Skp2, and biological functions of Skp2, thus providing the molecular basis and the biological relevance underlying the aberrant cytosolic localization of Skp2 in tumorigenesis. 
MEtHODS
Mice, cell culture and reagents. MEFs from wild-type and Skp2
−/− mice were prepared as described 8, 39 . 293T, PC-3, COS-1 and IMR90 cells (from M. Pagano) were cultured in DMEM medium containing 10% FBS, and LNCaP cells were grown in RPMI medium containing 10% FBS. To clone Xp-Skp2, Skp2 was amplified by the polymerase chain reaction (PCR) using pcDNA3-Skp2 as a template and inserted into a pcDNA4/HisMax-TOPO vector (Invitrogen). To clone GFP-Skp2, Skp2 was amplified by PCR using pcDNA3-Skp2 as a template and inserted into pcDNA3.1/NT-GFP-TOPO vector (Invitrogen). pcDNA3-Skp2 S72A, pcDNA3-Skp2 S72D, Xp-Skp2 S64A, Xp-Skp2 S64D, Xp-Skp2 S72A, Xp-Skp2 S72D and GFP-Skp2 S72A constructs were generated with a site-directed mutagenesis kit (Stratagene) in accordance with the manufacturer's standard procedure. The Skp2-NES construct was generated by fusing the nuclear export signal (NES) (ELALKLAGLDINKTE) to the C terminus of Skp2. MSCV-PIG-Skp2-NES was generated by subcloning Skp2-NES into the Xho1 site of the MSCV-PIG vector. pBabe-Skp2, pBabe-Skp2 S72A and pBabe-Skp2 S72D were generated by subcloning Skp2, Skp2 S72A and Skp2 S72D into the EcoRI site of the pBabe vector. GFP-PRKRLKS (from Skp2), GFP-PRKRLKA (from Skp2 S72A), GFP-PRKRLKD (from Skp2 S72D) and GFP-PKKKRKVD (from SV40 large T antigen) constructs were generated by introducing the peptide encoding sequence in frame at the 3´ end of the GFP coding sequence in a pcDNA3.1/NT-GFP-TOPO vector (Invitrogen). His 6 -ubiquitin, haemagglutinin-tagged p27 and pGEX-4X1-Skp1 constructs were gifts from D. Bohmann, M. Pagano and P. Jackson, respectively. To clone Xp-mSkp2, the mouse Skp2 complementary DNA was amplified by RT-PCR from MEFs and was inserted into pcDNA4/HisMax-TOPO vector. Flag-Skp2 and Flag-∆N-Skp2 were from W. Wei. The p27-T187A construct was from M. H. Lee. IGF-1, EGF, MG132, U0126, rapamycin and LY294002 were obtained from Calbiochem. Wortmannin was purchased from Sigma. GST-Akt1 and recombinant active Akt1 were obtained from Cell Signaling.
Immunoprecipitation, immunoblotting and immunofluorescence.
Immunoprecipitation (IP), immunoblotting (IB) and immunofluorescence (IF) were performed as described 39, 40 . For protein-protein interaction, cells were lysed in E1A lysis buffer (250 mM NaCl, 50 mM HEPES pH 7.5, 0.1% Nonidet P40, 5 mM EDTA, protease inhibitor cocktail (Roche)). The following antibodies were used for IP, IB or IF: anti-Skp2 (IP: 1:250; IB: 1:1,000; IF: 1:100; Zymed), anti-Skp2 (IB 1:1,000; Santa Cruz), anti-phospho-(S473)-Akt (IB: 1:1,000; Cell Signaling), anti-Akt1 (IB: 1:1,000; Cell Signaling), anti-phospho-Akt substrate antibody (IB: 1:1,000; Cell Signaling), anti-Skp1 (IP: 1:200; IB: 1:1000; BD Transduction Lab), anti-14-3-3β (IP: 1:100; IB: 1:2,000; Santa Cruz), anti-14-3-3γ (IB: 1:500; Santa Cruz), phospho-(S72)-Skp2 antibody (IB: 1:1,000; Pocono Rabbit Farm and Laboratory Inc.), anti-Xpress (IP and IF: 1:500; IB: 1:5,000; Invitrogen), antihaemagglutinin (IB and IF, 1:1,000; Covance, Upstate), anti-α-tubulin (IB: 1:1,000; Sigma), anti-β-actin (IB: 1:1,000; Sigma), anti-GFP (IP: 1:500; IB: 1:1,000; BD Clontech), anti-p27 (IP: 1:100; IB: 1:1,000; BD Transduction Lab) and anti-E2F1 (IB: 1:500; Santa Cruz).
In vitro and in vivo phosphorylation assay. The in vitro phosphorylation assay was performed as described 41 . In brief, GFP-Skp2 or GFP-Skp2 S72A was immunoprecipitated with GFP antibody from 293T cells cultured in DMEM medium containing 0.5% FBS. Immune complexes were washed three times in RIPA lysis buffer (150 mM NaCl, 10 mM Tris-HCl pH 7.5, 1% Nonidet P40, 0.5% deoxycholate, 0.1% SDS, protease inhibitor cocktail (Roche)), then washed twice in 1 × kinase buffer (25 mM Tris-HCl pH 7.5, 5 mM β-glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na 3 VO 4 , 10 mM MgCl 2 , 2 µM unlabelled ATP), and incubated with 1 µl recombinant active Akt1 kinase and 2 µCi of [γ-32 P]ATP in 50 µl total reaction buffer for 30 min at 30 °C. Reactions were stopped by washing twice in kinase buffer and boiling in 2 × SDS loading buffer. Proteins were resolved by 8% SDS-PAGE and transferred to the nitrocellulose membrane, and 32 P incorporation was detected by autoradiography. For in vivo labelling experiments, 293T cells were transfected with the indicated plasmids for 24 h, and the medium was changed to phosphate-free DMEM with 0.25% dialysed FBS containing 200 µCi ml −1 ortho-32 PO 4 for 4 h. Cells were lysed by RIPA buffer for immunoprecipitation and the Skp2 immune complex was subjected to 8% SDS-PAGE, followed by autoradiography.
Identification of phosphorylation sites by mass spectrometry. Gel-resolved proteins from in vitro and in vivo phosphorylation reactions were digested with trypsin and batch purified on a reverse-phase (RP) micro-tip; an aliquot was analysed by MALDI-reTOF mass spectrometry (MS; UltraFlex TOF/TOF; Bruker Daltonics, Bremen, Germany) for peptide mass fingerprinting, as described 41, 42 . This served to confirm the identity of the proteins and to locate possible differences between the tryptic peptide maps of the phosphorylated and unphosphorylated forms. The remainder of the RP-eluted digest mixtures was then subjected to immobilized gallium(III) affinity chromatography for selective capture of phosphopeptides, followed by elution with phosphate buffer, desalting over an RP tip, and a second round of MALDI-reTOF MS 20 . Peak m/z values were matched to the protein sequence, allowing for the likely presence of one or more phosphate groups. Mass spectrometric sequencing of the putative phosphopeptides was then performed by MALDI-TOF/TOF MS/MS analysis with the UltraFlex instrument in 'LIFT' mode. Fragment ion spectra were inspected for the characteristic partial loss of 98 Da, indicating the presence of phosphoserine or phosphothreonine, and for the a´´, b´´ and y´´ ions to compare with the computer-generated fragment ion series of the predicted tryptic peptides to locate the exact position of phosphoamino acids.
Ubiquitylation assay in vitro and in vivo. In vitro p27 ubiquitylation assays were performed essentially as described 4 . In brief, the Skp2-SCF complex was immunoprecipitated from 293T cells and mixed with in vitro-translated 35 S-p27 that had previously been incubated with cyclin E/Cdk2 for in vitro phosphorylation along with methylated ubiquitin and ubiquitin aldehyde for 60 min at 30 °C. The reaction was stopped with 2 × SDS sample buffer and run on polyacrylamide gels. In vivo ubiquitylation assays were performed as described 43 . In brief, 293T cells were transfected with the indicated plasmids for 24 h, treated with vehicle, 20 µM LY294002 or 100 nM wortmannin together with 20 µM MG132 for 6 h, and lysed in denaturing buffer (6 M guanidine-HCl, 0.1 M Na 2 HPO 4 /NaH 2 PO 4 , 10 mM imidazole). The cell extracts were then incubated with nickel beads for 3 h, washed, and subjected to western blot analysis.
Cell growth and in vivo tumorigenesis assay. Bromodeoxyuridine incorporation assays were performed with the In Situ Cell proliferation Kit (Fluos; Roche). LNCaP stable transfectant cells were generated as described 44 . In brief, LNCaP cells were transfected with pcDNA3, pcDNA3-Skp2 or pcDNA3-Skp2 S72A and selected with G418 (300 µg ml A mono-phosphorylated peptide was identified in the spectra of "Skp2-P"that was absent from the spectra of "Skp2-C and S72A-P", and confirmed by MALDI-TOF/TOF MS/MS sequencing:
Excised, in gel trypsin-digested, and analyzed by MALDI-reTOF mass spectrometry 
RNA interference
293T cells were transfected with 14-3-3β or 14-3-3γ or nonspecific control siRNA using Oligofectamine reagent (Invitrogen) according to manufacturer's instructions. In brief, 100 nM final concentration of siRNA was used to transfect cells at 50 % confluency. DMEM with 10% FBS. Cells were allowed to migrate for 18 hours in a humidified chamber at 37°C with 5% CO2. After the incubation period, the filter was removed and non-migrant cells on the upper side of the filter were detached using a cotton swab.
Filters were fixed with 4% formaldehyde for 15 min and cells located in the lower filter were stained with 0.1% crystal violet for 20 min and counted from three random fields.
For the in vitro wound scratch assay, MEFs were grown to confluency and wounds were made using sterile pipette tips. Cells were washed in phosphate buffer saline (PBS) and
